Cantor Fitzgerald Comments on Elutia FY2025 Earnings

Elutia Inc. (NASDAQ:ELUT) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Elutia in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn expects that the company will post earnings of ($0.95) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $10.00 target price on the stock. The consensus estimate for Elutia’s current full-year earnings is ($1.76) per share.

Elutia Trading Down 0.9 %

Elutia stock opened at $3.22 on Wednesday. The firm has a market capitalization of $111.28 million, a PE ratio of -1.23 and a beta of 0.89. Elutia has a 12-month low of $2.28 and a 12-month high of $5.24. The firm has a 50-day moving average price of $3.89 and a 200-day moving average price of $3.82.

Institutional Investors Weigh In On Elutia

Several hedge funds and other institutional investors have recently modified their holdings of the business. Arcus Capital Partners LLC boosted its stake in shares of Elutia by 100.0% during the third quarter. Arcus Capital Partners LLC now owns 20,000 shares of the company’s stock valued at $76,000 after purchasing an additional 10,000 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Elutia by 50.5% during the second quarter. Renaissance Technologies LLC now owns 53,616 shares of the company’s stock valued at $266,000 after purchasing an additional 18,000 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Elutia by 50.3% in the 3rd quarter. Geode Capital Management LLC now owns 188,408 shares of the company’s stock valued at $718,000 after acquiring an additional 63,047 shares during the period. Perkins Capital Management Inc. boosted its position in Elutia by 9.8% during the third quarter. Perkins Capital Management Inc. now owns 856,552 shares of the company’s stock valued at $3,263,000 after purchasing an additional 76,450 shares in the last quarter. Finally, Nantahala Capital Management LLC grew its position in shares of Elutia by 8.8% in the 2nd quarter. Nantahala Capital Management LLC now owns 1,795,697 shares of the company’s stock worth $8,907,000 after buying an additional 145,697 shares during the last quarter. 74.03% of the stock is currently owned by hedge funds and other institutional investors.

Elutia Company Profile

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.